| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Rallybio Corporation Common Stock (NASDAQ: RLYB)
RLYB Technical Analysis
4
| As on 9th Jun 2023 RLYB STOCK Price closed @ 7.89 and we RECOMMEND Sell for LONG-TERM with Stoploss of 10.02 & Strong Sell for SHORT-TERM with Stoploss of 11.03 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RLYBSTOCK Price
| Open | 7.84 | Change | Price | % |
| High | 8.16 | 1 Day | 0.06 | 0.77 |
| Low | 7.66 | 1 Week | 1.54 | 24.25 |
| Close | 7.89 | 1 Month | 2.85 | 56.55 |
| Volume | 89000 | 1 Year | -2.33 | -22.80 |
| 52 Week High 15.04 | 52 Week Low 4.31 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| RLYB Daily Charts |
RLYB Intraday Charts |
Whats New @ Bazaartrend |
RLYB Free Analysis |
|
|
RLYB Important Levels Intraday
| RESISTANCE | 8.85 |
| RESISTANCE | 8.54 |
| RESISTANCE | 8.35 |
| RESISTANCE | 8.16 |
| SUPPORT | 7.62 |
| SUPPORT | 7.43 |
| SUPPORT | 7.24 |
| SUPPORT | 6.93 |
RLYB Forecast May 2024
| 4th UP Forecast | 22.11 |
| 3rd UP Forecast | 17.55 |
| 2nd UP Forecast | 14.73 |
| 1st UP Forecast | 11.91 |
| 1st DOWN Forecast | 3.87 |
| 2nd DOWN Forecast | 1.05 |
| 3rd DOWN Forecast | -1.77 |
| 4th DOWN Forecast | -6.33 |
RLYB Weekly Forecast
| 4th UP Forecast | 14.42 |
| 3rd UP Forecast | 12.33 |
| 2nd UP Forecast | 11.03 |
| 1st UP Forecast | 9.74 |
| 1st DOWN Forecast | 6.04 |
| 2nd DOWN Forecast | 4.75 |
| 3rd DOWN Forecast | 3.45 |
| 4th DOWN Forecast | 1.36 |
RLYB Forecast2024
| 4th UP Forecast | 30.51 |
| 3rd UP Forecast | 23.26 |
| 2nd UP Forecast | 18.77 |
| 1st UP Forecast | 14.29 |
| 1st DOWN Forecast | 1.49 |
| 2nd DOWN Forecast | -2.99 |
| 3rd DOWN Forecast | -7.48 |
| 4th DOWN Forecast | -14.73 |
Rallybio Corporation Common Stock ( NASDAQ USA Symbol : RLYB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RLYB Business Profile
Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a preclinical-stage monoclonal anti-HPA-1a antibody for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company is also developing RLYB211, a polyclonal anti-HPA-1a antibody that is in a Phase 1/2 clinical trial for the prevention of FNAIT; RLYB114, a pegylated C5 inhibitor in preclinical development for the treatment of complement-mediated ophthalmic diseases; and RLYB116, a subcutaneously administered inhibitor of complement factor 5, or C5, for the treatment of patients with paroxysmal nocturnal hemoglobinuria and generalized myasthenia gravis. The company also has discovery-stage programs that are focused on the identification of small molecule therapeutics for patients with rare metabolic diseases. Rallybio has collaboration with Exscientia for the development of small molecule therapeutics for rare diseases. Rallybio Corporation was incorporated in 2018 and is headquartered in New Haven, Connecticut. Rallybio Corporation operates as a subsidiary of Rallybio Holdings, LLC. Address: 234 Church Street, New Haven, CT, United States, 06510
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service